Accelerated Pharmaceuticals has moved operations in Augusta to the following address:
3528 Stevens Way
Augusta, Georgia 30907
February 5, 2004 Accelerated Pharmaceuticals Press Release
Accelerated Pharmaceuticals Announces Novel Drug Discovery Technology Based Upon The Human Genome:
Discovery Provides Compelling Evidence For The Genomic
Action of New Drug Candidates: See News
December 4, 2003 New Patent Pending Discoveries
API's Scientific Team Discovers Process To Fundamentally Change The Design
And Selection Of Drugs
Researchers at Accelerated Pharmaceuticals Inc. (API) have recently discovered compelling evidence that nuclear receptors and other nuclear proteins function by delivering drugs to specific gene sequences with remarkable precision and accuracy. This patented, patent pending and proprietary technology provides a method to speed drug discovery and create unique, safe and effective drugs that encompass greater than 10% of the current global market of $400 billion. This technology can also predict inherent and subtle toxicities of drugs that are not detectable by other methods.
|
Precise alignment of estrogen (space filling image) in DNA (blue) and receptor (yellow). The alignment of drugs in gene sequences and nuclear receptors was recently discovered at API to be a common phenomenon resulting in a powerful patent pending technology for drug discovery (See details under Breaking News and Patents & Publications)
|
The implications of the patent pending discoveries include:
- New Drugs For Previously Untreatable Diseases
- New Methods To Detect Side Effects And Toxicities Of Drugs
- Novel Structure/Activity Relationships Not Possible With Other Methods
- Novel Screening Methods To Find Drug Candidates
- Methods To Detect And Correct Genetic Abnormalities
Targets for drugs developed with this technology include diabetes, osteoporosis, prostate cancer, breast cancer, fertility, sexual dysfunction, cardiovascular disease, arthritis, skin cancer, thyroid disease, hormone replacement, stroke, neuroprotection and obesity.
Additional information on these are related discoveries will be posted under Breaking News and Patents & Publications
. For information on business or investment opportunities, call 412-298-4200.
Background Information
Accelerated Pharmaceuticals Inc. (API) is a drug discovery company focused on speeding the design and development of novel, safe, and effective pharmaceuticals through the use of proprietary and patented gene-based technologies.
API' s technology specifically addresses the crisis in the pharmaceutical industry resulting from the relative paucity of
New Chemical Entities (NCEs) in pharmaceutical pipelines by developing rapid and cost effective computational methods to identify such new drug candidates. The technology concomitantly excludes from consideration candidate molecules unlikely to possess activity prior to synthesis and biological testing thereby saving valuable time and resources.
